TRAX
First Tracks Biotherapeutics, Inc.
34.40$
-3.9%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
First Tracks Biotherapeutics, Inc. (TRAX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -32 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 25 | Q2 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|
| -45 | -39 | -33 | -32 | |
| 0.6 | 0.6 | 0.1 | 0.2 | |
| 7.7 | 7.7 | 12 | 8.3 | |
| -4.5 | -2.9 | 6.3 | -7.2 | |
| 0.0 | 0.0 | 0.0 | 0.0 | |
| 15 | – | 35 | 0.0 | |
| 5.7 | -52 | 7.9 | -49 | |
| -24 | -54 | 10 | -80 | |
| -45 | -39 | -33 | -32 |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.